Detalles de la búsqueda
1.
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancer.
Gynecol Oncol
; 185: 128-137, 2024 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38412736
2.
A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinoma.
BJU Int
; 133 Suppl 3: 57-67, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37986556
3.
Patients' perception of the benefits of palliative systemic therapy for advanced cancer.
Intern Med J
; 54(5): 735-741, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38205872
4.
Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer.
Gynecol Oncol
; 166(2): 254-262, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35718565
5.
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study.
Int J Gynecol Cancer
; 32(6): 761-768, 2022 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35086926
6.
PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer.
Cochrane Database Syst Rev
; 10: CD012160, 2019 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31588998
7.
Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS).
Gynecol Oncol
; 148(1): 36-41, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29107348
8.
Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study.
Oncologist
; 22(9): 1117-1124, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28596446
9.
The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study.
Oncologist
; 21(5): 618-25, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27009937
10.
Patient-Reported Outcomes in Ovarian Cancer: Facilitating and Enhancing the Reporting of Symptoms, Adverse Events, and Subjective Benefit of Treatment in Clinical Trials and Clinical Practice.
Patient Relat Outcome Meas
; 14: 111-126, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37188148
11.
Effect Sizes Hypothesized and Observed in Contemporary Phase III Trials of Targeted and Immunological Therapies for Advanced Cancer.
JNCI Cancer Spectr
; 2(4): pky037, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31360867
12.
Clinical Equipoise for Trials of Novel Biologic Therapies, Therapeutic Success Rates, and Predictors of Success: A Meta-Analysis.
JCO Precis Oncol
; 1: 1-12, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35172509
Resultados
1 -
12
de 12
1
Próxima >
>>